Test Code TOBRA Tobramycin, Random, Serum
Useful For
Monitoring adequacy of serum concentration during tobramycin therapy
This unit code is used whenever a specimen is submitted or collected without collection timing information. The phlebotomist should use this unit code if she or he does not know if this is a peak or trough specimen.
Method Name
Immunoassay
Reporting Name
Tobramycin, Random, SSpecimen Type
SerumOrdering Guidance
Serum for a peak level should be drawn 30 to 60 minutes after last dose (order TOBPA / Tobramycin, Peak, Serum).
Serum for a trough level should be drawn no more than 30 minutes before next scheduled dose (order TOBTA / Tobramycin, Trough, Serum).
Specimen Required
Preferred: Serum gel
Acceptable: Red top
Specimen Volume: 0.5 mL
Collection Instructions:
1. Serum gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged and aliquoted within 2 hours of collection.
Specimen Minimum Volume
0.25 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Reject Due To
Gross hemolysis | Reject |
Reference Values
TOBRAMYCIN, PEAK
Therapeutic: 3.0-12.0 mcg/mL
Toxic: >12.0 mcg/mL
TOBRAMYCIN, TROUGH
Therapeutic: <2.0 mcg/mL
Toxic: >2.0 mcg/mL
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 2 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
TOBRA | Tobramycin, Random, S | 35670-9 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
TOBRA | Tobramycin, Random, S | 35670-9 |
NY State Approved
YesCPT Code Information
80200
Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.